Cargando…
Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke
Ischemic stroke (IS) is a serious cerebrovascular disease with high morbidity and disability worldwide. Despite the great efforts that have been made, the prognosis of patients with IS remains unsatisfactory. Notably, recent studies indicated that mesenchymal stem cell (MSCs) therapy is becoming a n...
Autores principales: | Guo, Yinghan, Peng, Yucong, Zeng, Hanhai, Chen, Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219421/ https://www.ncbi.nlm.nih.gov/pubmed/34221026 http://dx.doi.org/10.1155/2021/9923566 |
Ejemplares similares
-
The Role of Neutrophil Extracellular Traps in Central Nervous System Diseases and Prospects for Clinical Application
por: Guo, Yinghan, et al.
Publicado: (2021) -
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
por: Doeppner, Thorsten R, et al.
Publicado: (2010) -
DNase-1 Treatment Exerts Protective Effects in Neurogenic Pulmonary Edema via Regulating the Neutrophil Extracellular Traps after Subarachnoid Hemorrhage in Mice
por: Wu, Xinyan, et al.
Publicado: (2022) -
Treatment of ischemic stroke with modified mesenchymal stem cells
por: Chen, Hao, et al.
Publicado: (2022) -
Progress in Stem Cell Therapy for Spinal Cord Injury
por: Gao, Liansheng, et al.
Publicado: (2020)